Senokot-s
c24cdc5e-62e0-41a6-8afb-512202a569f4
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Drug Facts
Medication Information
Warnings and Precautions
Warnings
Indications and Usage
Drug Facts
Dosage and Administration
Directions
- take preferably at bedtime or as directed by a doctor
| age | startingdosage | maximumdosage |
| adults and children 12 years of age and over |
2 tablets oncea day | 4 tablets twicea day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
Dosage Forms and Strengths
Other information
- each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
- store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)
Description
Drug Facts
Section 50565-1
Keep out of reachof children.
In case ofoverdose, get medical help or contact a Poison Control Center rightaway.
Section 50566-9
Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.
Section 50567-7
Uses
- relieves occasional constipation (irregularity)
- generally produces a bowel movement in 6-12 hours
Section 50569-3
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues overa period of 2 weeks
Section 50570-1
Do not use
- if you are now taking mineral oil, unless directed by adoctor
- laxative products for longer than 1 week unless directedby a doctor
Section 51727-6
Inactive ingredients
Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin
©2020
Avrio Health L.P.
A1023
Section 51945-4
Senokot-S 60 Tablets Label
NDC: 67618-310-60
Senokot-S 60 Tablets Leaflet
NDC: 67618-310-60
Senokot-S 60 Tablets Carton
NDC: 67618-310-60
Senokot-S 10 Tablets Carton
NDC: 67618-310-01
Section 53414-9
If pregnant or breast-feeding, ask a health professional before use.
Section 55105-1
Purpose
Stool softener
Laxative
Section 55106-9
Active ingredients (in each tablet)
Docusate sodium 50mg
Sennosides 8.6mg
Structured Label Content
Indications and Usage (34067-9)
Drug Facts
Dosage and Administration (34068-7)
Directions
- take preferably at bedtime or as directed by a doctor
| age | startingdosage | maximumdosage |
| adults and children 12 years of age and over |
2 tablets oncea day | 4 tablets twicea day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
Dosage Forms and Strengths (34069-5)
Other information
- each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
- store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)
Warnings and Precautions (34071-1)
Warnings
Section 50565-1 (50565-1)
Keep out of reachof children.
In case ofoverdose, get medical help or contact a Poison Control Center rightaway.
Section 50566-9 (50566-9)
Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.
Section 50567-7 (50567-7)
Uses
- relieves occasional constipation (irregularity)
- generally produces a bowel movement in 6-12 hours
Section 50569-3 (50569-3)
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues overa period of 2 weeks
Section 50570-1 (50570-1)
Do not use
- if you are now taking mineral oil, unless directed by adoctor
- laxative products for longer than 1 week unless directedby a doctor
Section 51727-6 (51727-6)
Inactive ingredients
Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin
©2020
Avrio Health L.P.
A1023
Section 51945-4 (51945-4)
Senokot-S 60 Tablets Label
NDC: 67618-310-60
Senokot-S 60 Tablets Leaflet
NDC: 67618-310-60
Senokot-S 60 Tablets Carton
NDC: 67618-310-60
Senokot-S 10 Tablets Carton
NDC: 67618-310-01
Section 53414-9 (53414-9)
If pregnant or breast-feeding, ask a health professional before use.
Section 55105-1 (55105-1)
Purpose
Stool softener
Laxative
Section 55106-9 (55106-9)
Active ingredients (in each tablet)
Docusate sodium 50mg
Sennosides 8.6mg
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:07:58.117765 · Updated: 2026-03-14T23:12:00.901105